Super-Pharm Overcharges for Basic Products, Investigation Finds
Translated & summarized from Now 14 by baba
An investigation by C14 found that Super-Pharm charges significantly higher prices for basic hygiene and cleaning products compared to competitors. The report detailed price differences for five everyday items, highlighting systematic overcharging that impacts Israeli consumers facing high living costs.
The story in 5 lines · by baba
- Super-Pharm overcharges for basic products, an investigation found.
- Price differences range from tens to hundreds of percent higher.
- Five specific products showed significant price discrepancies.
- Consumers are urged to compare prices to save money.
- The practice is described as systematic overcharging.
An investigation by C14 has revealed that the Israeli pharmacy chain Super-Pharm sells basic hygiene and cleaning products at significantly higher prices compared to other pharmacies and major food chains. The report highlights that consumers pay tens to hundreds of percent more for these everyday items at Super-Pharm, underscoring the financial impact of not comparing prices.
The investigation detailed price discrepancies for five specific products. For instance, a 2-liter bottle of 'Ritzpaz Plus Sno' floor cleaner, priced at 23.90 shekels at B-Pharm, costs 25.90 shekels at Super-Pharm. Similarly, a 700ml bottle of 'Sno Anti Kalk 4-in-1' general cleaning spray is sold for 18.90 shekels at Super-Pharm, versus 17.90 shekels at B-Pharm. A 2-liter bottle of 'Fresh Home Ritzpaz' floor concentrate costs 22.90 shekels at Super-Pharm, compared to 19.90 shekels at B-Pharm. Even a 50ml tube of Colgate Smiles toothpaste for ages 2-5 is priced at 13.90 shekels at Super-Pharm, while Gabi-Pharm sells it for 18.90 shekels. A 1-liter bottle of 'Rosenblum Pearl Pink' liquid soap is 19.90 shekels at Super-Pharm, significantly higher than the 15.20 shekels charged at B-Pharm.
These findings suggest that shopping at Super-Pharm is not just a matter of convenience but represents a systematic overcharging of consumers. The report concludes that this practice is an unfavorable deal for Israelis already grappling with the rising cost of living.